The induction of sensory organ placodes, in particular the lens placode, represents the paradigm for induction. We show that medaka Sox3 is expressed in the neuroectoderm and in the placodes of all sensory organs prior to placode formation and subsequently in placode-derived tissues. Ectopic Sox3 expression leads to ectopic expression of Pax6 and Eya1 in embryonic ectoderm and causes ectopic lens and otic vesicle formation. The descendants of cells ectopically expressing Sox3-mRNA contribute to ectopic lens tissue. This suggests a permissive role for Sox3 in establishing a placodal competence. In addition, ectopic Sox3 expression leads to the dysgenesis of the endogenous sensory organs. Both effects of ectopic Sox3 expression can be separated by ectopic expression of a truncated Sox3 variant depending on its expression level. Our data suggests that Sox3 is a permissive factor for sensory placode formation and plays an important role in sensory organ development. q
Introduction
The development of the sensory organs and in particular the eye is a paradigm for induction during vertebrate development (Spemann, 1901; Jacobson, 1966; Grainger, 1996) . Essential components of the nose, eye, and ear develop from surface ectodermal derivatives, the sensory placodes, local thickenings of the ectoderm that are the ®rst morphological sign of ectodermal contributions to the forming vertebrate sense organs (Webb and Noden, 1993) . These placodes give rise to the olfactory epithelium, the lens, the cranial ganglia, and the inner ear, respectively. While the nasal and lens placodes are located in the anterior ventral head ectoderm, the otic placode originates more dorsally in the posterior head ectoderm adjacent to the prospective rhombencephalon.
All sensory placodes initially develop in a similar pattern, as they invaginate into their surrounding tissue and in the case of lens and otic vesicles subsequently delaminate to form a separated vesicle. Tranplantation experiments and recent genetic studies in amphibians and ®sh provide evidence that sensory placode formation in the head ectoderm is induced by the neuroectoderm and cephalic mesendoderm during late gastrula and neurula stages. (Jacobson, 1966; Jacobson and Sater, 1988; Gallagher et al., 1996; Grainger, 1996; Mendonsa and Riley, 1999) .
So far, only a few molecules that are involved in sensory placode development have been identi®ed. Among them are the transcription factors Pax6 and Eya1. In Pax6 homozygous mutant mice the formation of the nasal and lens placodes does not occur leading to a subsequent loss of the nasal pit, lens and entire eye (Hill et al., 1991; Grindley et al., 1995) . Loss of function mutations in a human homologue of the Drosophila eyes absent gene (eya) lead to defects or the loss of the placode-derived inner ear and are the cause of deafness in the human Branchio-Oto-Renal syndrome (Abdelhak et al., 1997) .
Expression in all sensory placodes has been reported for Sox2 and Sox3, during early stages of sensory placode development in frog, chick, and mouse embryos (Uwanogho et al., 1995; Collignon et al., 1996; Penzel et al., 1997; Zygar et al., 1998) . However, their function in embryonic development remains elusive. SOX transcription factors contain a highly conserved High Mobility Group (HMG) domain (Laudet et al., 1993) which in the case of the SOX1,2,3-subgroup is located in the N-terminus. Within the SOX subfamily this domain binds to DNA with high www.elsevier.com/locate/modo af®nity in a sequence speci®c manner. In addition, in several SOX family members a C-terminal transactivation domain has been identi®ed, which, in the case of SOX2, has been shown to activate the transcription of lens-speci®c crystallin genes directly (Kamachi et al., 1995 (Kamachi et al., , 1998 .
Functionally, SOX transcription factors have been implicated in cell fate decisions during embryogenesis. Mutations in the human SRY gene, the founding member of the Sox transcription factor family, leads to sex reversal (Berta et al., 1990; Koopman et al., 1990) . Misexpression of Sry in the mouse causes cells destined to become ovaries to differentiate into testes (Koopman et al., 1991) . Furthermore Sox1, a member of the Sox1,2,3-subgroup, when ectopically expressed in P19 cells, which otherwise have the potential to differentiate into cell types of all three germ layers (McBurney, 1993) , mediates P19 cells to differentiate into neural cell types in vitro (Pevny et al., 1998) . This ®nding together with the placodal expression of other Sox family members (Uwanogho et al., 1995; Collignon et al., 1996; Penzel et al., 1997; Zygar et al., 1998) suggests that Sox genes are important for the proper development of the placode-derived components of the sense organs.
Here we report the isolation of a Sox3 homologue from the medaka ®sh (Oryzias latipes) which is expressed in the entire neuroectoderm, in the presumptive placodal ectoderm prior to placode formation and subsequently in all placodes of the sensory organs. Ectopic Sox3 activity leads to the ectopic expression of Pax6 and Eya1 in the embryonic ectoderm, consistent with ectopic formation of placode-derived tissues. Ectopic Sox3 expression elicits the formation of ectopic lenses and otic vesicles in the ectoderm of developing embryos. This suggests a permissive role for Sox3 as a competence factor for neural and placode induction.
Ectopic expression of Sox3 also results in the dysgenesis of the endogenous eye and ear. Ectopic expression of a truncated variant of Sox3 containing the HMG DNA-binding domain allowed the experimental separation of ectopic placode formation from the dysgenesis of the sensory organs. At low doses the DNA-binding of the Sox3-HMGdomain is suf®cient to elicit ectopic placode formation. At higher doses however it results in eye and ear dysgenesis which is likely to be caused by a dominant-negative effect of ectopic Sox3 expression.
Results

Isolation of medaka Sox3
A cDNA-fragment of the medaka (Oryzias latipes) Sox3 homolog was ampli®ed by RT-PCR. This fragment was subsequently used to screen a neurula stage cDNA library, which lead to the isolation of a full-length (1786 bp) Sox3 cDNA. The deduced amino acid sequence (300 aa) shows highest similarity to the Sox3 transcription factor from chick (84% aa identity) and contains in its N-terminal region a highly conserved DNA-binding HMG-domain of 79 aa. This HMG-domain is most closely related to HMG-domains of SOX3-and SOX2-homologues from other vertebrates (95±91% aa identities, Fig. 1 ). At the C-terminus, the ORF encodes another conserved domain, which has recently been shown to act as transcriptional activator in other SOX 2,3 proteins (Kamachi et al., 1998) . This C-terminal domain of the medaka cDNA shows higher similarity to vertebrate SOX3-proteins (67±56% aa-similarity) than to the respective SOX2 sequences (49±47% aa-similarity; Fig. 1 ). These ®ndings indicate that the isolated cDNA encodes the medaka SOX3-protein.
2.2. Sox3 is expressed in the neuroectoderm and the ectodermal placodes of the sensory organs during early medaka embryogenesis
In situ hybridization detected Sox3 expression in the entire ectoderm, elevated in the prospective head ectoderm as well as in the marginal zone of the epiblast shortly after the onset of gastrulation (50% epiboly), the earliest stage analyzed ( Fig. 2A) . During subsequent stages Sox3 expression is found in the entire ectoderm ( Fig. 2A±C ) and persists in the neuroectoderm along the entire body axis in the forming and differentiating CNS (Fig. 2D±F ) with the exception of the¯oorplate. During early somitogenesis, neural expression of Sox3 is downregulated in the outbudding optic vesicle. At late organogenesis stages, Sox3 expression in the central nervous system (CNS) becomes restricted to the germinal zones (not shown).
Outside the developing CNS Sox3 is initially expressed throughout the entire ectoderm at neurula stages. Two bilateral domains of elevated Sox3 expression in the surface ectoderm laterally¯ank the CNS at the level of the prospective rhombencephalon (Fig. 2C, arrows) and become subsequently more con®ned (Fig. 2D ,E, arrowheads). This expression persists until the onset of somitogenesis. At this stage Sox3 is expressed in the ectoderm opposing the forming optic vesicle (Fig. 2E ) and the nasal pit (Fig. 2E,F) . Sox3 expression, which is initially distributed over the entire anterior head ectoderm, progressively becomes con®ned to the nasal pit, the lens vesicle, and distinct cells in the rhombencephalic ectoderm (Fig. 2F) forming the otic placode. Sox3 expression in the ectodermally derived tissues of the sense organs persists until organogenesis and is detected in the olfactory epithelium (Fig. 2G, arrowheads) , the differentiating lens (Fig. 2H) , and inner ear (Fig. 2I) .
Expression in tissues of the forming sensory placodes is in good accordance with the expression reported for mouse and chick Sox3 homologues (Uwanogho et al., 1995; Collignon et al., 1996) . Expression relates well to the one reported for Xenopus by Penzel et al. (1997) , which is in con¯ict to the data reported by Zygar et al. (1998) during lens bias and speci®cation period.
As an independent marker for placodal tissue we employed the medaka eyes absent 1 (Eya1) gene. Homolo- gues of the Drosophila gene eyes absent (eya) gene have been cloned from mice and are expressed in an overlapping manner in all cranial placodes (Xu et al., 1997) . A PCRcloned medaka Eya-fragment of 762 bp (see methods) was used to screen a neurula stage cDNA-library. Several partial cDNAs were isolated, the longest of which is 2071 bp in length. Sequence analysis revealed that this cDNA contains an ORF encoding a putative protein with a C-terminal EYAdomain, a highly conserved region of 271 amino acids. The isolated medaka EYA-domain shows the highest homology to the human (95.2% aa identity) and mouse (93.7% aa identity) EYA1 homologues, identifying the isolated cDNA as a medaka Eya1 homologue. During early somitogenesis, Eya1 expression is found in the anterior-most head ectoderm (Fig. 2K , note that Eya1 expression is excluded from the prospective lens placode region) and subsequently in the nasal placode (data not shown). In addition, Eya1 expression in a longitudinal thickening of the rhombencephalic ectoderm demarcates the otic placode Fig. 2K ). Later it is expressed in the otic vesicle (data not shown). The overlapping expression pattern of medaka Eya1 and Sox3 in the posterior head ectoderm indicates that the Sox3 expressing cells in the rhombencephalic head ectoderm belong to the otic placode (compare Fig. 2J ,K). During organogenesis medaka Eya1 is expressed in the olfactory epithelium ( Fig. 3D ) and the inner ear, derivatives of the nasal and otic placodes ( Fig. 6D ) but not in the lens (Fig.  3D ).
Misexpression of Sox3 results in ectopic ectodermal activation of Pax6 and Eya1
Sox3 is expressed in the presumptive sensory placodal ectoderm and becomes re®ned to the sensory placodes and their derivatives. To investigate whether ectopic Sox3 effects the expression of placode marker genes we analyzed the expression of Pax6and Eya1. Pax6 is expressed in the nasal and lens placodes (Grindley et al., 1995; Loosli et al., 1998) . As a marker for the nasal and the otic placode we analyzed Eya1 expression.
Sox3-mRNA was injected into a single blastomere at the two-cell stage and embryos were analyzed for Pax6 expression by whole-mount in situ hybridization after 2 days of development (st. 27), prior to the stage when ectopic placode-derived tissue becomes morphologically obvious (see below). Ectopic Pax6 expression in the ectoderm was detected at a frequency of 12.1% (16/132, Table 1 ). In detail, ectopic expression of Pax6 was found in the lateral and ventral head ectoderm, mainly between the lens and the otic vesicle (Fig. 3B, arrowhead) . Less frequently we detected ectopic Pax6 expression in the anterior ectoderm between the nasal pits ( Fig. 3C, arrowhead) , and rarely in lateral head ectoderm posterior to the otic vesicle (not shown). However, cells ectopically expressing Pax6 were never found in dorsal head ectoderm or the ectoderm¯ank-ing the trunk.
Eya1 is also ectopically expressed in the ectoderm of Sox3-injected embryos at a frequency of 16.7% (25/125, Table 1 ). Ectopic Eya1 expression is observed in the anterior head ectoderm that joins the two nasal pits which are normally separated by anterior non-Eya1-expressing head ectoderm (Fig. 3D,E) . Ectopic expression of Eya1 is also activated in the dorsal head ectoderm (Fig. 3F,G) as well as in dorsal (Fig. 3H,I ) and lateral (not shown) trunk ectoderm. In some cases, cells ectopically expressing Eya1invaginate into the underlying neuroectoderm (Fig. 3I, arrowhead) . In control-injected embryos ectopic expression of Pax6 (0/ 156, Table 1 ; Fig. 3A) or Eya1 (0/167, Table 1 ; Fig.  3D,F) was not observed.
Ectopic Sox3 activity leads to ectopic lens and otic vesicle formation in the ectoderm
As ectopic expression of Sox3 resulted in the ectopic expression of the early placodal markers Pax6 and Eya1 we next asked whether ectopic Sox3 expression leads to the ectopic formation of differentiating placodal tissues.
After 3 days of development (st. 34, organogenesis) Sox3-injected embryos displayed the formation of lens-like and otic vesicle-like structures at ectopic locations in the embryonic ectoderm. Ectopic lens-like structures are surrounded by an epithelium and were found in the lateral and ventral head ectoderm (24/255, Table 1 ; Figs. 3B,C and 4B, arrowhead). Ectopic expression of Sox3 also resulted in the formation of vesicular structures resembling otic vesicles by morphological criteria (8/289, Table 1 ). These vesicles were located in the dorso-lateral trunk ectoderm adjacent to the neural tube (Fig. 4C, arrowhead) .
To unambiguously identify the ectopic structures as lenses and otic vesicles Sox3-injected embryos were analyzed using tissue speci®c markers. All of the Sox3-injected embryos, which displayed ectopic spherical structures (9,4%, 24/255, Table 1 ), expressed the lens ®ber speci®c a-crystalline gene ectopically (Fig. 4B ). This indicates that the ectopic expression of Sox3 leads to the formation of differentiating lenses at ectopic locations in the ectoderm. The ectopic lenses formed exclusively in the lateral (Fig. 4B ) and ventral head ectoderm (data not shown) and were not observed in the dorsal head or trunk ectoderm. Thus, the frequency and location of the forming ectopic lenses is consistent with the restriction of ectopic Pax6 expression to these domains. It is noteworthy that ectopic lenses never replaced endogenous placodederived tissues such as the nasal pit or the otic vesicle. In control-injected embryos neither ectopic lens-like structures nor cells ectopically expressing a-crystalline were observed (0/255, Table 1) indicating that ectopic lens formation is a speci®c result of ectopic Sox3 expression.
For the analysis of the ectopic vesicles we used Eya1 and Pax2 as markers which, in wild-type embryos, are coexpressed only in the ear (Fig. 2J,K) . Morphologically visible ectopic vesicles in the posterior lateral ectoderm form in 2.8% (8/289, Table 1) of the Sox3-mRNA injected embryos. Double in situ analysis revealed that Pax2 and Eya1, as in normal otic vesicles, are coexpressed in these structures (Fig. 4C, inset) . This shows that ectopic Sox3 activity in addition to ectopic lens formation can also result in the formation of ectopic otic vesicles. In control-injected embryos the formation of ectopic otic vesicles was never found (0/335, Table 1 ).
Descendants of Sox3-injected blastomeres contribute to the ectopic lenses
With respect to ectopic lens formation ectopic Sox3 can either act in the inducing or induction signal receiving tissue. In the former case descendants of the Sox3-injected blastomere will not contribute to ectopic lens tissue while endogenous Eya1 expression restricted to nasal pits, (F) no Eya1 expression is found in dorsal head ectoderm or (H) trunk ectoderm. Note that Eya1 trunk expression is con®ned to somites. In Sox3-injected embryos ectopic expression of Eya1 is found (E) in anterior head ectoderm joining nasal pits or (G) further dorsally in dorsal telencephalic ectoderm. (I) Trunk cells ectopically expressing Eya1 form invaginating structures (arrowhead) in dorsal ectoderm overlying neural tube. l, lens; np, nasal pit; otv, otic vesicle; tel, telencephalon.
they will do so in the latter. To address if cells, which express Sox3 ectopically, contribute to the forming ectopic lenses we coinjected Sox3-and lacZ-mRNA encoding a nuclear-b-galactosidase into single blastomeres of 8-cellstage medaka embryos. The injected embryos were stained for b-galactosidase activity after 2 days of development. Subsequently the expression of a-crystalline was analyzed by whole-mount in situ hybridization using the¯uorescent substrate FastRed. In the ectopic lenses formed in response to Sox3-injection b-gal activity is detected, which partially overlaps with a-crystalline expression (Fig. 5A,B) . This demonstrates that descendants of the initially injected blastomere are not excluded from the ectopic lenses, but do contribute to these ectopic tissues. This suggests that ectopic Sox3 expression renders ectodermal cells competent to respond to placode inducing factors. Outside of placodal tissue lacZ-expressing cells were also found in the surface ectoderm. This hints at a permissive role for Sox3 in the establishment of a placodal identity in embryonic ectodermal cells.
Ectopic Sox3 expression results in dysgenesis of endogenous sensory organs
Ectopic expression of Sox3 results besides ectopic lens and otic vesicle formation in a second morphological effect, the dysgenesis of the endogenous sensory organs. Injected embryos show a reduction (Fig. 6B, arrowhead) or loss (Fig.  6C ) of endogenous eyes (61/255, Table 1 ). This abnormal eye development is already obvious at the onset of somitogenesis by a diminished or even absent evagination of the optic vesicles from the lateral walls of the neural tube, a developmental stage when the optic vesicles normally still express Sox3 in wild-type embryos (compare Fig. 2D ). Similar to the dysgenesis of the eyes in a number of the injected embryos (32/262, Table 1 ; Fig. 6D ), otic vesicles were reduced in size or even lost. This indicates that for proper development of the optic and otic vesicle the total level of Sox3 expression is critical. In control-injected embryos the eye (0/292, Table 1) or otic vesicle (0/335, Table 1 ) developed normally, demonstrating that the dysgenesis of the sense organs is speci®cally due to the ectopic expression of the Sox3. Sox3-injected embryo with ectopic lens (arrowhead) located in lateral head ectoderm between endogenous lens and otic vesicle. Note spherical shape of a-crystallin positive tissue, identifying lens-®ber cells. Like endogenous lens, ectopic lens is surrounded by lens epithelium. (C) Sox3-injected embryo stained for Pax2-(blue) and Eya1-expression (red). An ectopic otic vesicle (arrowhead) expressing both Pax2 and Eya1 (see inset) located in dorso-lateral ectoderm of the trunk adjacent to neural tube. l, lens; lep, lens epithelium; ot, optic tectum; otv, otic vesicle; rh, rhombencephalon. 
The Sox3 HMG-domain phenocopies the effects of ectopic Sox3 expression
To investigate whether the formation of ectopic placodal tissue and the dysgenesis of sensory organs observed upon ectopic Sox3 expression can be mimicked by one of the two known functional domains of Sox3, we generated a truncated variant of medaka Sox3, Sox3D. This encodes the DNA-binding HMG-domain and a part of the linker region, but not the transactivation domain (Figs. 1 and 7A) . Doseresponse analysis by mRNA injection into two-cell-stage embryos showed that the frequency of ectopic lens formation increases with raising mRNA-concentration and peaks at 175 ng/ml (20/137, Table 2 ). At this concentration ectopic lenses formed in 14.6% of the injected embryos ( Fig. 7B ; 20/137, Table 2 ). However, only 2.2% of the embryos showed reduced eyes (3/137, Table 2 ). Further increase of the Sox3D-mRNA concentration to 250 and 320 ng/ml, respectively, leads to a drop in the frequency of ectopic lens formation to 2±5% (Table 2) . At these concentrations eye dysgenesis appears in 20.4% of the injected embryos (28/137, Table 2 ; Fig 7C) . In control-injections using GFPmRNA, neither ectopic lens formation nor dysgenesis of the eyes was observed, demonstrating that the effects are speci®c for ectopic expression of Sox3D (Table 2) .
Thus in ectopic expression studies the HMG-DNA-binding-domain is suf®cient to elicit both effects obtained with full length Sox3 in a concentration dependent manner. While ectopic lens formation peaks at lower concentrations the dysgenesis of the eye requires higher effective Sox3D concentrations (Fig. 7D) . This hints at a dominant negative role for Sox3D under these conditions causing the dysgenesis of sensory organs, which express Sox3 endogenously.
Discussion
Medaka Sox3 is a candidate for rendering ectodermal cells competent to differentiate into placode-derived tissues
Induction processes play a critical role during placode development. Competence factors act in the induction signal receiving tissue in a permissive manner to enable a cell to become induced and to subsequently contribute to a distinct tissue.
We have isolated a medaka homologue of the Sox3 gene, which during gastrulation is initially expressed ubiquitously in the ectoderm. Subsequently, Sox3 expression becomes restricted to the neuroectoderm and placodes of the sensory organs and persists in the placode-derived differentiating tissues. Thus, the endogenous spatio-temporal expression of Sox3 matches the dynamic competence for sensory placode formation in the ectoderm as described by transplantation analysis in amphibians (Jacobson, 1963; Grainger, 1992; Gallagher et al., 1996) . Sox3-expression is already observed at the onset of gastrulation and thus precedes the expression of lens-inducing signals during late gastrulation stages (Grainger, 1992) . Expression of Sox3 in the head ectoderm already during early gastrulation indicates that SOX3 acts prior to lens induction in the ecto- derm and makes it unlikely that Sox3-expression is a response of ectodermal cells having already received a lens-inducing signal. Thus, the endogenous expression of Sox3 is consistent with SOX3 being involved in the establishment of a placodal competence in the ectoderm rather than in transducing lens inducing signals inside prospective placodal cells.
If Sox3 expression in the ectoderm permits sensory placode formation, genes expressed in these placodes should be activated ectopically in mRNA injection experiments. In wild-type embryos surface ectodermal expression of Pax6 (nasal and lens placode) and Eya1 (nasal and otic placode) is observed in the sensory placodes. In Sox3 injected embryos expression of both Pax6 and Eya1 was detected at ectopic locations in the ectoderm. This suggests that ectopic placodal cells are generated upon ectopic Sox3 activity. As these ectopic placodes arise in a locally restricted manner and not over the entire ectoderm (see also below) suggests that other factors in addition to SOX3 are involved in establishing a placodal competence.
The formation of ectopic lenses and ectopic otic vesicles in Sox3 injected embryos indicates that ectopic expression of Sox3 in the ectoderm not only leads to the ectopic expression of early placodal genes but also permits ectodermal cells to differentiate into placode-derived structures. Since descendants from lacZ-and Sox3-mRNA coinjected cells were found inside the ectopically formed lenses and were not excluded from the endogenous or ectopic placodederived tissues, Sox3 functions inside the induced tissue, the endogenous or ectopic placode. The proposed permissive role for Sox3 in ectopic placode formation is consistent with the ®nding that not all b-galactosidase expressing descendants from the Sox3 injected blastomere were located in placode-derived tissues. These cells, although competent for placodal fates may have missed respective inductive signals.
Sox3 expression in placodal tissues might not only be involved in mediating a placodal competence. Endogenous expression of Sox3 in the placode derived tissues long after placode formation rather suggests that Sox3 is also involved in later steps of placode differentiation. The frequency of ectopic placode formation of 12 (ectopic Pax6 expression) to 16% (ectopic Eya1 expression, see Table 1 ) in the injected embryos may re¯ect this later requirement that can not be achieved by mRNA injections.
Ectopic Sox3 might mediate a principal placodal competence that is further speci®ed by regionalizing factors
The nasal epithelium, lens, and otic vesicle seem to be induced by similar mechanisms during the early phases of their development. Such a general placodal ground state is evident through the similarity of the sequential inductive processes of lens and otic vesicle formation as revealed by transplantation experiments in Xenopus laevis embryos (Jacobson, 1966; Gallagher et al., 1996) .
During gastrulation of amphibian embryos initially the entire ectoderm is competent to develop into a lens (Jacobson, 1966; Grainger, 1992) or an otic vesicle. For the lens this capacity is subsequently restricted to the lateral and ventral head ectoderm of amphibian and chick embryos and is lost in other ectodermal cells (Jacobson, 1966; Barabanov and Fedtsova, 1982; Grainger, 1992) while the posterior head ectoderm becomes biased to form the otic placode (Gallagher et al., 1996) . Subsequently as development proceeds the placodes get further speci®ed by the distinct local cellular environment (Jacobson, 1963) . In wild-type embryos surface ectodermal expression of Pax6 is found in the nasal and lens placodes while Eya1 is detected in the nasal and otic placodes. The spatial restriction of both ectopic Pax6-expression and successive formation of ectopic lenses exclusively in the ventro-lateral head ectoderm in Sox3-mRNA-injected medaka embryos is in accordance with these classical competence studies. The Eye dysgenesis needs higher concentrations than ectopic placode formation and is steadily increasing until severe gastrulation defects followed by lethality are predominant (see also text and Table 2 ).
®nding of ectopic Eya1 expression upon ectopic Sox3-expression in cells of the posterior and dorsal head-and trunk-ectoderm is consistent with the more dorsal origin of the otic placode. Accordingly, ectopic otic vesicles were located exclusively in the dorso-lateral part of the head ectoderm posterior to the ectopic lenses and in the dorso-lateral ectoderm¯anking the trunk. We therefore suggest that Sox3 confers to ectodermal cells a principal placodal competence. Upon the activity of regionalizing factors the forming ectopic placodes adopt a distinct identity (nasal, lens, otic) according to their position in the ectoderm. As shown previously, ectopic expression of Six3 by DNA injection in medaka is capable of inducing ectopic lenses close to the otic vesicle or replacing the otic vesicle with a lens (Oliver et al., 1996) . Sox3 RNA-injection however did not result in ectopic expression of Six3 in the ectoderm (data not shown). The surprising ®nding that ectopic otic vesicles also form in the trunk ectoderm shows that in principle also in the trunk otic placode induction can occur once ectodermal cells have been rendered competent to respond to these factors due to ectopic Sox3 expression. Whether also ectopic nasal placodes were generated in Sox3-mRNA injected embryos can only be addressed indirectly due to the lack of appropriate nasal-speci®c marker genes in medaka. However, ectopic overlapping expression of Pax6 and Eya1 in the anterior head ectoderm (compare Fig. 3C ,E) argues for ectopic nasal placode formation as the nasal placode is the only ectodermal tissue, in which these two genes are coexpressed.
3.3. Ectopic expression of the Sox3-HMG-domain alone allows separation of ectopic placode formation from sensory organ dysgenesis
The SOX3 protein contains two main functional domains, the DNA-binding HMG-domain in its N-terminus and a transcriptional activation domain, which is located in the C-terminus. Separating these two domains leads to a separation of the two effects observed in ectopic Sox3 expression studies, namely ectopic placode formation and sensory organ dysgenesis. Lower amounts of the N-terminal HMG-containing domain (Sox3D) lacking also most of the linker region between these two domains (see Fig. 1 ) resulted in the ectopic formation of lenses and otic vesicles without sensory organ dysgenesis. With rising mRNA concentrations of Sox3D, dysgenesis of the sensory organs increases and eventually leads to lethality of the injected embryos. This shows that Sox3D can functionally replace wild-type Sox3 in a concentration dependent manner.
Dose response analysis using Sox3D shows that ectopic placode formation is a consequence of low-level, Sox3D expression. A dominant-negative function was demonstrated in detail for an analogously truncated version of Sox2 (Johnson et al., 1998) . Consequently, at higher expression levels, endogenous Sox3 function is affected dominantnegatively resulting in the dysgenesis of the endogenous sensory organs. In mouse the phenotypes obtained after inactivation of Sox1 (Nishiguchi et al., 1998) are similar to the injection of high amounts of Sox3D further substantiating the suggested dominant negative activity of Sox3D at high concentrations. Wild-type Sox3-mRNA very potently leads to both morphological effects, ectopic placode formation and sensory organ dysgenesis already at minute concentrations not allowing a dose response analysis. The results obtained with Sox3D suggest that wild-type Sox3 already at lowest concentrations acts in a dominant-negative way in the endogenous Sox3 expression domains resulting in sensory organ dysgenesis while at ectopic locations ectopic placodes are elicited as a gain of Sox3-function at the same time.
How can wild-type Sox3 and Sox3D mediate combinatorial effects of gain and loss of function when expressed ectopically? HMG-domain transcription factors, and also SOX2 the closest paralogue of SOX3, form ternary complexes with transcriptional activators and DNA (Kamachi and Kondoh, 1993; Zwilling et al., 1995; Behrens et al., 1996; Zappavigna et al., 1996; Kuhlbrodt et al., 1998; Kamachi et al., 1999) . This protein-protein interaction together with the DNA-binding of each of the partners is essential for synergistic transcriptional activation. On its own, the Sox2 DNA- binding domain is incapable of transcriptional activation (Ambrosetti et al., 1997; Kuhlbrodt et al., 1998; Kamachi et al., 1999) . However, for ternary complex formation the HMG domain alone is suf®cient (Kamachi et al., 1999) . The interface of the protein-protein interaction comprises the conserved (Fig. 1 ) DNA-binding HMG-domain and the linker region between the HMG and transactivation domains. Our ®ndings suggest that low ectopic Sox3D expression similar to the expression of its full-length form mediates the recruitment of Sox3-binding transactivators to their common target sites. Subsequent transcriptional activation mediated by the transactivator results in the generation of an ectopic placodal competence and eventually leads to ectopic placode formation. However, high ectopic concentrations of Sox3D will force protein-protein interactions interfering with the balance of SOX3-heterodimer and ternary complex formation. We suggest that this disturbed ternary complex eventually results in the loss of transcriptional activation of Sox3 target genes causing the observed dominant negative effect and endogenous sensory organ dysgenesis. As wild-type Sox3 contains the entire linker region its binding ef®ciency to co-transactivators should be ef®cient (at least 5±6-fold in analogy to Sox2, Kamachi et al. 1999) ) and result in a dominant-negative effect already at minute ectopic concentrations not clearly separable from the gain of function concentrations by performing mRNAinjections.
Materials and methods
Fish maintenance
Wild-type Oryzias latipes from a closed stock at the MPI of Biophysical Chemistry were kept as described (Ko Èster et al., 1997) . Staging of the embryos was performed according to Iwamatsu (1994) .
Isolation of medaka Sox3 and Eya1
A 671-bp Sox3-fragment was ampli®ed by RT-PCR from total RNA isolated from the prospective head region of neurula stage embryos (st. 17) using degenerate primers speci®c for the Sox1,2,3subgroup (5 H -AARMGICCIAT-GAAYGCITTYATG, 3
H -TACATISWIATCATRTCICK-IARRTCICC). PCR-conditions were: 5 cycles 948C, 1 min; 458C, 2 min; 728C, 4 min; 30 cycles 948C, 1 min; 508C, 2 min; 728C, 4 min. The resulting PCR-product was cloned into pCRII (Invitrogen), sequenced and used to screen a late neurula medaka l ZAP cDNA library at high stringency. Positive phages were plaque puri®ed, converted into Bluescript SK and sequenced (EMBL accession#: AJ245396)
A 762 bp long Eya1 fragment was ampli®ed by PCR from medaka genomic DNA using degenerate primers designed on the basis of highly sequence conserved regions within the EYA domains of Drosophila eyes absent and mouse Eya genes (upper primer GTGTTMSTCTGGGAYCTGGAC-GAGAC and lower primer GTGRSYGGAGA YSCKCCA-GAAGG). PCR conditions were: 4 min, 948C; 5 cycles: 1 min, 948C, 2 min, 488C, 2 min, 728C; 35 cycles: 1 min, 948C, 2 min, 538C, 2 min, 728C. The resulting PCR product was cloned into pCRII, sequenced and used to screen a neurula stage l ZAP cDNA library under high stringency. Positive phages were puri®ed, converted into Bluescript SK, and sequenced (EMBL accession#: AJ245395).
4.3. Whole-mount in situ hybridization, sectioning and bgalactosidase activity staining Whole-mount in situ hybridization and sectioning of stained embryos was performed as described (Ko Èster et al., 1997) with the modi®cation of an increased temperature of 658C in all hybridization and washing steps. In all double labelings the NBT/BCIP (blue) staining was performed ®rst, followed by the FastRed detection (red). Staining for bgalactosidase was performed prior to whole-mount in situ hybridization as described (Joore et al., 1996) .
RNA injections
The open reading frame of the Sox3-cDNA DraI/AvrII fragment (1052 bp) was subcloned into pCS21 (Rupp et al., 1994) . Sox3D (391 bp) was generated by DraI/NarIdigestion of the Sox3-cDNA and subcloning into pCS21. Capped RNA for injections was transcribed from linearized vectors using the SP6 mMESSAGE mMACHINE Kit (Ambion). Individual blastomeres of 2±16-cell stage embryos were injected as described (Ko Èster et al., 1997) After initial injections of different dilutions (10, 30, 50 and 100 ng/ml) the concentration of Sox3-mRNA and gfpmRNA for controls was 30 ng/ml. For coinjections capped mRNA encoding nuclear b -galactosidase was transcribed from pCSnbgal (Rupp et al., 1994) and added to the injection solution at a concentration of 100 ng/ml.
